2015-08-29 16:20:44 UTC

Join the Discussion on IBD Imaging this Fall

Aug. 31, 2015

Join AGA on Oct. 2, 2015, in Washington, DC, to discuss new trends in endoscopic evaluation in IBD.

New trends in endoscopic evaluation of IBD will impact the design and interpretation of future clinical trials. AGA's Center for Diagnostics and Therapeutics invites you to engage with key opinion leaders this October in Washington, DC, at Endoscopic Disease Activity Evaluation in IBD: Factors Influencing Disease Activity Interpretation in Clinical Practice and Clinical Trials.

The conference will discuss "local" versus "centralized" reading of endoscopic images to assess disease activity, including the positives and negatives of both approaches. Representatives from FDA will be present to provide insight on the agency's perspective and position regarding these important issues. All clinical and industry professionals with an interest in IBD clinical trials are encouraged to attend. 

We hope you'll join us Oct. 2, 2015. The early registration deadline ends Thursday, Sept. 3. Hotel reservations must be made no later than Tuesday, Sept. 8.

To register today, visit www.gastro.org/cdt15.

More on Continuing Education

2018 AGA Postgraduate Course

June 2, 2018

Secure your spot for this clinically focused, multi-topic course that offers immediately applicable information. Held in conjunction with DDW®. Save $75 when you register by April 18.

Advancing Collaborative Approaches in IBD Treatment Decision-Making

March 14, 2018

This is a unique opportunity for payers and providers to gather in the same room to discuss IBD therapy selection, disease monitoring, treatment criteria and access.

Fellows: Are You Cognitively or Procedurally Driven?

Feb. 8, 2018

Before you can market yourself, you have to know who your market is, and, more importantly, know who you are.